Oncotarget is a journal that publishes free papers online every week that are available to everyone. They also include an option for users to print these documents. The intent of Oncotarget is to spread the public’s knowledge by making various scientific research results available as soon as they are released. This will allow new discoveries to be shared more quickly and it will also build a bridge between different specialities in order to make the communities more accessible to each other. This also has worked to encourage collaboration in biomedical sciences. Oncotarget is considered to a revolutionary advance in the sharing network inside of the medical field. It is going to lead a great system of information and will greatly increase the access that everyone, including the public and medical professionals, have to the plethora of research that is being gathered every day. Download output styles at Endnote.com.
Since their main goal is to end all disease, Oncotarget decided to focus specifically on combating cancer. They have made huge strides in the organization of all of this information and this has benefited the families of those who are suffering from cancer because they have access to a greater amount of information about the disease. The journal focuses specifically on potential therapy treatments and the current standing of treatment protocols. It focuses on the perspective of the patient and uses that to generate ideas for improved and more innovative management programs. They also worked with therapeutic agencies in order to further that sector. They supply their readers with all the evidence that is backing this research, and they discuss the potential therapies that could come into effect in the future. Oncotarget is thriving under the impressive leadership hands of Mikhail Blagosklonny and Andrei V. Gudkov, the editors in chief of the journal. Oncotarget runs through the intricate Index Medicus abstract. They run a highly efficient system and they are growing in popularity with authors in the medical field. In addition to their focus on oncology, Oncotarget also has in depth information on chromosomes, stems cells, neuroscience, cell diseases, gerotarget, and pathology. They also publish papers about age related disease, immunology, and endocrinology.